Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases Vaccines Low-dose Administration of MERS DNA Vaccine Candidate Induces Potent Immunity and Protects From Virus Challenge in Preclinical Models By Staff Reports 9 months ago A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The
Antibiotics Biotechnology Centers for Disease Control Clinical Trials Coronavirus Coronavirus COVID-19 Healthcare IT News Infection Control Infectious Diseases rare diseases Research & Discovery Vaccines Vaccine development software shows promise in influenza effort, could help defeat coronavirus By Staff Reports 11 months ago A novel computer algorithm that could create a broadly reactive influenza vaccine for swine flu
Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Moderna’s virus vaccine shows overwhelming success in U.S. tests By Staff Reports 1 year ago Moderna said Monday its COVID-19 vaccine is proving highly effective in a major trial, a
cancer Cancer Discovery Cell Therapy Vaccines New nanotechology design provides hope for personalized vaccination for treating cancer By Staff Reports 1 year ago One of the key challenges in developing effective, targeted cancer treatments is the heterogeneity of
Biotechnology Clinical Trials Coronavirus rare diseases Vaccines Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults By Staff Reports 1 year ago A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown
Biotechnology Centers for Disease Control Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Antibody responses in COVID-19 patients could guide vaccine design By Staff Reports 1 year ago A comprehensive analysis of antibody responses in coronavirus disease 2019 (COVID-19) patients could inform the
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Vaccines Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses By Staff Reports 1 year ago Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show
Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Vaccines CEL-SCI Announced Early Results with COVID 19 LEAPS Vaccine/Treatment By Staff Reports 1 year ago CEL-SCI Corporation announces that it has concluded animal experiments using its LEAPS COVID 19 conjugate
Biotechnology cancer Cell Therapy Clinical Trials Vaccines Experiments in Mice And Human Cells Shed Light On Best Way to Deliver Nanoparticle Therapy For Cancer By Staff Reports 2 years ago Researchers in the cancer nanomedicine community debate whether use of tiny structures, called nanoparticles, can
Biotechnology Coronavirus Infectious Diseases Prescriptions Research & Discovery Vaccines Patients with More Severe Forms of Coronavirus Disease Could Offer Clues to Treatment By Staff Reports 2 years ago Hundreds of clinicians worldwide are banding together in an effort to study some types of severe cases
rare diseases Vaccines World Health Organization declares Coronavirus a Pandemic By Staff Reports 2 years ago The World Health Organization said Wednesday the coronavirus that causes COVID-19 and that has infected
Biotech Company News Biotechnology Infectious Diseases Vaccines Biotech Moderna Ships mRNA Vaccine Against Novel Coronavirus Human Studies By Staff Reports 2 years ago Moderna, Inc.,has released the first batch of mRNA-1273, the Company’s vaccine against the novel coronavirus,
Biotechnology cancer Clinical Trials Immunotherapies Vaccines John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma By Staff Reports 2 years ago John Theurer Cancer Center at Hackensack University Medical Center is the only site in New
Biotechnology cancer Vaccines Immunological discovery opens new possibilities for using antibodies By Staff Reports 3 years ago Many of the immune defence reactions are launched in the lymph nodes. For instance, small,
Infectious Diseases Vaccines H3N2 viruses mutate during vaccine production but new tech could fix it By Staff Reports 3 years ago In late March 2019, the World Health Organization and a vaccine advisory committee of the
Infectious Diseases Vaccines H3N2 viruses mutate during vaccine production but new tech could fix it By Staff Reports 3 years ago In late March 2019, the World Health Organization and a vaccine advisory committee of the
Immunotherapies Infectious Diseases Vaccines Developing a Vaccine Against Nipah Virus By Staff Reports 3 years ago Nipah virus is a type of RNA virus transmitted from animals to humans. The infection
Vaccines Revealing the Gut’s B-Cell Training Program May Point to New Means of Developing Oral Vaccines By Staff Reports 3 years ago Only a few vaccines – for example, polio and rotavirus – can be given orally.
Environmental Health Personal Health & Wellness Vaccines Measles outbreak: Many states are inadequately vaccinated according to expert By Staff Reports 3 years ago As several reports emerge highlighting measles outbreaks across the country, Virginia Tech infectious disease expert points
Vaccines Repeat Vaccination Is Safe for Most Kids with Mild to Moderate Reactions By Staff Reports 3 years ago Children who experience some type of adverse event following initial immunization have a low rate of